People’s willingness to buy local vaccines
By Hsieh Yen-yau 謝炎堯
On Jan. 3, the Indian government granted emergency use authorization for the COVID-19 vaccine Covaxin developed by Bharat Biotech International Ltd. Indian news media praised the move, calling it the pride of the nation.
Covaxin was researched and developed by Bharat Biotech in collaboration with India’s National Institute of Virology and the Indian Council of Medical Research, using the same technology platform as China’s vaccines.
The institute and the council provided the virus strain in May last year, and in July commenced phase 1 and phase 2 clinical trials, which were carried out in 12 Indian hospitals selected by the council.
Increasing R&D Studies to Develop Cancer Vaccines Attributed to Spike in Number of Cancer Patients
- Financialnewsmedia.com News Commentary
Share this article
Share this article
PALM BEACH, Fla., Feb. 18, 2021 /PRNewswire/ Ovarian cancer and its rising incidence rate is a growing concern worldwide and the rising incidence of ovarian cancer will be driving the ovarian cancer drugs market for years to come. Ovarian cancer is regarded as one of the most common types of cancer among women. It accounts for more deaths than any other cancer of the female reproductive system, while it ranks 5th in overall women deaths due to cancer. This type of cancer is rarely diagnosed at an early stage, making treatment at an advanced stage difficult. According to American Cancer Society estimates, risk of any woman acquiring ovarian cancer in her lifetime is 1 in 75, while her chance of death due to ovarian cancer is 1 in 100. Ovarian cancer is more prevalent among elderly women, making women ov
Financial News Media | Increasing R&D Studies to Develop Cancer Vaccines Attributed to Spike in Number of Cancer Patients financialnewsmedia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialnewsmedia.com Daily Mail and Mail on Sunday newspapers.
Association between metabolically healthy obesity/overweight and cardiovascular disease risk: A representative cohort study in Taiwan Roles Data curation, Methodology, Validation
Affiliations Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan, Department of Family Medicine, Taipei MacKay Memorial Hospital, Taipei, Taiwan ⨯
Ming-Chieh Tsai, Roles Methodology, Validation
Affiliations Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan, Division of Endocrinology, Department of Internal Medicine, MacKay Memorial Hospital, Tamsui Branch, New Taipei City, Taiwan, Department of Medical Research, MacKay Memorial Hospital, New Taipei City, Taiwan ⨯
Le-Yin Hsu,
Affiliation Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan
Synergistic effect between NF-κB inhibitors and zinc in vitro reducing ACE2 expression
Researchers at National Taiwan University Hospital in Taipei have conducted a study demonstrating the potential effectiveness of a novel drug combination at reducing morbidity and mortality in coronavirus disease 2019 (COVID-19).
In a study using two human cell lines, a combination of the clinical drugs triclabendazole and emetine effectively suppressed expression of the host cell receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Furthermore, this suppressive effect was enhanced by the addition of zinc sulfate, suggesting that zinc supplementation might further increase the potential clinical application of the drug combination for COVID-19 prevention and treatment.